» Articles » PMID: 2154189

Heterogeneity of [3H]inositol 1,4,5-trisphosphate Binding Sites in Adrenal-cortical Membranes. Characterization and Validation of a Radioreceptor Assay

Overview
Journal Biochem J
Specialty Biochemistry
Date 1990 Jan 15
PMID 2154189
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

1. The characterization of a radioreceptor assay for determining Ins(1,4,5)P3 concentration in tissue extracts is described which utilizes the binding of [3H]Ins(1,4,5)P3 to an adrenal-cortex membrane fraction. 2. Analysis of [3H]Ins(1,4,5)P3 binding by isotope dilution demonstrated an apparent single population of binding sites (KD 3.65 +/- 0.18 nM, Bmax. 872 +/- 70 fmol/mg of protein). Specific binding of [3H]Ins(1,4,5)P3 was enhanced at alkaline pH values (maximum at pH 8.5), with complete loss of specific binding at pH less than 6. These binding sites displayed strict stereo- and positional specificity for Ins(1,4,5)P3, with L-Ins(1,4,5)P3, Ins(1,3,4)P3 and DL-Ins(1,3,4,5)P4 causing 50% displacement of specific [3H]Ins(1,4,5)P3 binding (IC50 values) at concentrations of 14 +/- 3 microM, 3.0 +/- 0.3 microM and 0.53 +/- 0.03 microM respectively. 3. Kinetic analysis of binding data, however, revealed a high-affinity [3H]Ins(1,4,5)P3 binding site (KD 0.052 nM) in addition to the lower-affinity site (KD 2.53 nM) already demonstrated in displacement studies. 4. It is shown that the presence of the high-affinity site can be exploited to increase the sensitivity of the [3H]Ins(1,4,5)P3 radioreceptor assay, allowing accurate detection of 20 fmol of Ins(1,4,5)P3 in 300 microliters of tissue extract. 5. Further validation of the specificity of the above assay for Ins(1,4,5)P3 was provided by incubating tissue extracts with either a 5-phosphatase or 3-kinase preparation. It was shown that identical loss occurred of both Ins(1,4,5)P3 mass and [3H]Ins(1,4,5)P3, added to parallel incubations. 6. The ability of the assay to measure basal and agonist-stimulated increases in Ins(1,4,5)P3 concentration has been demonstrated with rat cerebral cortex and bovine tracheal smooth-muscle slices and a range of cultured and isolated cell preparations.

Citing Articles

Altered calcium signaling following traumatic brain injury.

Weber J Front Pharmacol. 2012; 3:60.

PMID: 22518104 PMC: 3324969. DOI: 10.3389/fphar.2012.00060.


Phosphoinositide signaling: new tools and insights.

Balla T, Szentpetery Z, Kim Y Physiology (Bethesda). 2009; 24:231-44.

PMID: 19675354 PMC: 3126675. DOI: 10.1152/physiol.00014.2009.


Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.

Kockskamper J, Zima A, Roderick H, Pieske B, Blatter L, Bootman M J Mol Cell Cardiol. 2008; 45(2):128-47.

PMID: 18603259 PMC: 2654363. DOI: 10.1016/j.yjmcc.2008.05.014.


A phosphatidylinositol phosphate-specific myo-inositol polyphosphate 5-phosphatase required for seedling growth.

Ercetin M, Ananieva E, Safaee N, Torabinejad J, Robinson J, Gillaspy G Plant Mol Biol. 2008; 67(4):375-88.

PMID: 18392779 DOI: 10.1007/s11103-008-9327-3.


Abscisic Acid-Induced Phosphoinositide Turnover in Guard Cell Protoplasts of Vicia faba.

Lee Y, Choi Y, Suh S, Lee J, Assmann S, Joe C Plant Physiol. 1996; 110(3):987-996.

PMID: 12226236 PMC: 157799. DOI: 10.1104/pp.110.3.987.


References
1.
Danoff S, Supattapone S, Snyder S . Characterization of a membrane protein from brain mediating the inhibition of inositol 1,4,5-trisphosphate receptor binding by calcium. Biochem J. 1988; 254(3):701-5. PMC: 1135141. DOI: 10.1042/bj2540701. View

2.
Supattapone S, Danoff S, Theibert A, Joseph S, Steiner J, Snyder S . Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proc Natl Acad Sci U S A. 1988; 85(22):8747-50. PMC: 282538. DOI: 10.1073/pnas.85.22.8747. View

3.
Worley P, Baraban J, Snyder S . Inositol 1,4,5-trisphosphate receptor binding: autoradiographic localization in rat brain. J Neurosci. 1989; 9(1):339-46. PMC: 6569993. View

4.
Enyedi P, Brown E, Williams G . Distinct binding sites for Ins(1,4,5)P3 and Ins(1,3,4,5)P4 in bovine parathyroid glands. Biochem Biophys Res Commun. 1989; 159(1):200-8. DOI: 10.1016/0006-291x(89)92423-6. View

5.
Palmer S, Hughes K, Lee D, Wakelam M . Development of a novel, Ins(1,4,5)P3-specific binding assay. Its use to determine the intracellular concentration of Ins(1,4,5)P3 in unstimulated and vasopressin-stimulated rat hepatocytes. Cell Signal. 1989; 1(2):147-56. DOI: 10.1016/0898-6568(89)90004-1. View